12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
周五盘后交易时段,12只医疗保健类股走势
Gainers
获胜者
- Intelligent Bio Solutions (NASDAQ:INBS) stock rose 8.6% to $2.14 during Friday's after-market session. The company's market cap stands at $4.9 million.
- MSP Recovery (NASDAQ:LIFW) shares increased by 6.68% to $0.23. The company's market cap stands at $76.1 million.
- Mesoblast (NASDAQ:MESO) stock increased by 5.0% to $4.2. The market value of their outstanding shares is at $683.4 million.
- Annexon (NASDAQ:ANNX) stock rose 4.98% to $3.37. The market value of their outstanding shares is at $178.8 million.
- Matinas BioPharma Hldgs (AMEX:MTNB) shares increased by 4.87% to $0.39. The market value of their outstanding shares is at $85.7 million.
- Renalytix (NASDAQ:RNLX) stock increased by 4.72% to $3.1. The market value of their outstanding shares is at $146.9 million.
- 智能生物解决方案 纳斯达克股票代码:INBS)股价在周五的盘后交易时段上涨8.6%,至2.14美元。该公司的市值为490万美元。
- MSP 恢复 纳斯达克股票代码:LIFW)股价上涨6.68%,至0.23美元。该公司的市值为7,610万美元。
- mesoblast 纳斯达克股票代码:MESO)股票上涨5.0%,至4.2美元。他们已发行股票的市值为6.834亿美元。
- Annexon 纳斯达克股票代码:ANNX)股价上涨4.98%,至3.37美元。他们已发行股票的市值为1.788亿美元。
- 马蒂纳斯生物制药控股公司 (AMEX: MTNB) 的股价上涨了4.87%,至0.39美元。他们已发行股票的市值为8,570万美元。
- Renalytix 纳斯达克股票代码:RNLX)股票上涨4.72%,至3.1美元。他们已发行股票的市值为1.469亿美元。
Losers
失败者
- OKYO Pharma (NASDAQ:OKYO) shares declined by 29.6% to $1.55 during Friday's after-market session. This security traded at a volume of 249.0K shares come close, making up 245.0% of its average volume over the last 100 days. The company's market cap stands at $39.5 million.
- Science 37 Hldgs (NASDAQ:SNCE) shares declined by 7.14% to $0.25. The market value of their outstanding shares is at $29.1 million.
- Impel Pharmaceuticals (NASDAQ:IMPL) stock fell 6.21% to $1.36. The market value of their outstanding shares is at $32.2 million.
- OptiNose (NASDAQ:OPTN) stock fell 5.99% to $1.1. The company's market cap stands at $123.1 million.
- eFFECTOR Therapeutics (NASDAQ:EFTR) shares decreased by 5.21% to $0.77. The company's market cap stands at $47.5 million.
- Navidea Biopharmaceutical (AMEX:NAVB) stock declined by 5.16% to $0.09. Navidea Biopharmaceutical's trading volume hit 2.9 million shares by close, accounting for 40.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $3.1 million. See Also:
- 东京制药 纳斯达克股票代码:OKYO)股价在周五的盘后交易时段下跌29.6%,至1.55美元。该证券的交易量接近24.9万股,占其过去100天平均成交量的245.0%。该公司的市值为3,950万美元。
- 科学 37 控股公司 纳斯达克股票代码:SNCE)股价下跌7.14%,至0.25美元。他们已发行股票的市值为2910万美元。
- Impel 制药 纳斯达克股票代码:IMPL)股价下跌6.21%,至1.36美元。他们已发行股票的市值为3,220万美元。
- optiNose 纳斯达克股票代码:OPTN)股价下跌5.99%,至1.1美元。该公司的市值为1.231亿美元。
- Effector 疗法 纳斯达克股票代码:EFTR)股价下跌5.21%,至0.77美元。该公司的市值为4,750万美元。
- Navidea 生物制药 (AMEX: NAVB) 股价下跌5.16%,至0.09美元。截至收盘,Navidea Biopharmaceutical的交易量达到290万股,占其过去100天平均交易量的40.5%。他们已发行股票的市值为310万美元。 另请参阅:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。